[HTML][HTML] The signal transducer IL6ST (gp130) as a predictive and prognostic biomarker in breast cancer
C Martínez-Pérez, J Leung, C Kay, J Meehan… - Journal of personalized …, 2021 - mdpi.com
Novel biomarkers are needed to continue to improve breast cancer clinical management
and outcome. IL6-like cytokines, whose pleiotropic functions include roles in many hallmarks …
and outcome. IL6-like cytokines, whose pleiotropic functions include roles in many hallmarks …
Cost-effectiveness of patient-matched pre-and on-treatment biomarkers in cancer therapy response prediction
G Tramonti - 2023 - era.ed.ac.uk
BACKGROUND: The development of new biomarkers allows for the accurate prediction of
breast cancer therapy response in the neoadjuvant setting. The implementation of these …
breast cancer therapy response in the neoadjuvant setting. The implementation of these …